Evolution of insulin at the edge of foldability and its medical implications
- 5 November 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (47), 29618-29628
- https://doi.org/10.1073/pnas.2010908117
Abstract
Proteins have evolved to be foldable, and yet determinants of foldability may be inapparent once the native state is reached. Insight has emerged from studies of diseases of protein misfolding, exemplified by monogenic diabetes mellitus due to mutations in proinsulin leading to endoplasmic reticulum stress and β-cell death. Cellular foldability of human proinsulin requires an invariant Phe within a conserved crevice at the receptor-binding surface (position B24). Any substitution, even related aromatic residue TyrB24, impairs insulin biosynthesis and secretion. As a seeming paradox, a monomeric TyrB24 insulin analog exhibits a native-like structure in solution with only a modest decrement in stability. Packing of TyrB24 is similar to that of PheB24, adjoining core cystine B19–A20 to seal the core; the analog also exhibits native self-assembly. Although affinity for the insulin receptor is decreased ∼20-fold, biological activities in cells and rats were within the range of natural variation. Together, our findings suggest that the invariance of PheB24 among vertebrate insulins and insulin-like growth factors reflects an essential role in enabling efficient protein folding, trafficking, and secretion, a function that is inapparent in native structures. In particular, we envision that the para-hydroxyl group of TyrB24 hinders pairing of cystine B19–A20 in an obligatory on-pathway folding intermediate. The absence of genetic variation at B24 and other conserved sites near this disulfide bridge—excluded due to β-cell dysfunction—suggests that insulin has evolved to the edge of foldability. Nonrobustness of a protein’s fitness landscape underlies both a rare monogenic syndrome and “diabesity” as a pandemic disease of civilization.Funding Information
- HHS | National Institutes of Health (R01 DK069764)
- HHS | National Institutes of Health (R01 DK48280)
- HHS | National Institutes of Health (R01 DK040949)
- HHS | National Institutes of Health (1F30DK112644)
- HHS | National Institutes of Health (5T32GM007250-38)
- American Diabetes Association (7-13-IN-31)
- American Diabetes Association (1-08-RA-149)
This publication has 87 references indexed in Scilit:
- Action of Protein Disulfide Isomerase on Proinsulin Exit from Endoplasmic Reticulum of Pancreatic β-CellsOnline Journal of Public Health Informatics, 2012
- Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youthTrends in Endocrinology & Metabolism, 2010
- Deciphering the Hidden Informational Content of Protein SequencesOnline Journal of Public Health Informatics, 2010
- Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin geneReviews in Endocrine and Metabolic Disorders, 2010
- Solution Structure of ProinsulinOnline Journal of Public Health Informatics, 2010
- Misfolded Proinsulin Affects Bystander Proinsulin in Neonatal DiabetesOnline Journal of Public Health Informatics, 2010
- Crystal Structure of a “Nonfoldable” InsulinOnline Journal of Public Health Informatics, 2009
- Proinsulin maturation, misfolding, and proteotoxicityProceedings of the National Academy of Sciences of the United States of America, 2007
- Insulin gene mutations as a cause of permanent neonatal diabetesProceedings of the National Academy of Sciences of the United States of America, 2007
- An exact mathematical expression for describing competitive binding of two different ligands to a protein moleculeFEBS Letters, 1995